S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

Definitive Healthcare Stock Forecast, Price & News

+0.56 (+2.44%)
(As of 07/1/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
612,120 shs
Average Volume
615,262 shs
Market Capitalization
$2.29 billion
P/E Ratio
Dividend Yield
Price Target

Definitive Healthcare Stock Forecast (MarketRank)

Analyst Rating
Moderate Buy
2.50 Rating Score
53.7% Upside
$36.10 Price Target
Short Interest
11.97% of Float Sold Short
Dividend Strength
News Sentiment
0.29mentions of Definitive Healthcare in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$283.15 K Sold Last Quarter
Proj. Earnings Growth
From $0.10 to $0.15 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.05 out of 5 stars

Medical Sector

644th out of 1,429 stocks

Prepackaged Software Industry

156th out of 302 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive DH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Definitive Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Definitive Healthcare logo

About Definitive Healthcare (NASDAQ:DH)

Definitive Healthcare Corp., together with its subsidiaries, provides healthcare commercial intelligence in the United States. Its solutions provide information on healthcare providers and their activities to help its customers in the area ranging from product development to go-to-market planning, and sales and marketing execution. The company's platform offers 16 intelligence modules that cover functional areas, such as sales, marketing, clinical research and product development, strategy, talent acquisition, and physician network management. It serves biopharmaceutical and medical device companies, healthcare information technology companies, and healthcare providers; and other diversified companies comprising staffing and commercial real estate companies, financial institutions, and other organizations in the healthcare ecosystem. Definitive Healthcare Corp. cwas founded in 2011 and is headquartered in Framingham, Massachusetts.

DH Stock News Headlines

Definitive Healthcare (NASDAQ:DH) Trading 8.1% Higher
Definitive Healthcare Corp (DH)
4 Analysts Have This to Say About Definitive Healthcare
See More Headlines

Industry, Sector and Symbol

Prepackaged software
Year Founded

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Price Target and Rating

Average Stock Price Forecast
High Stock Price Forecast
Low Stock Price Forecast
Forecasted Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
12 Analysts


Net Income
$-51.02 million
Pretax Margin


Sales & Book Value

Annual Sales
$166.15 million
Cash Flow
$0.88 per share
Book Value
$17.03 per share


Free Float
Market Cap
$2.29 billion
Not Optionable

Definitive Healthcare Frequently Asked Questions

Should I buy or sell Definitive Healthcare stock right now?

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Definitive Healthcare in the last twelve months. There are currently 6 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" Definitive Healthcare stock.
View analyst ratings for Definitive Healthcare
or view top-rated stocks.

What is Definitive Healthcare's stock price forecast for 2022?

12 brokerages have issued 12-month target prices for Definitive Healthcare's stock. Their DH stock forecasts range from $23.00 to $53.00. On average, they predict Definitive Healthcare's share price to reach $36.10 in the next year. This suggests a possible upside of 53.7% from the stock's current price.
View analysts' price targets for Definitive Healthcare
or view top-rated stocks among Wall Street analysts.

How has Definitive Healthcare's stock performed in 2022?

Definitive Healthcare's stock was trading at $27.33 on January 1st, 2022. Since then, DH shares have decreased by 14.1% and is now trading at $23.49.
View the best growth stocks for 2022 here

When is Definitive Healthcare's next earnings date?

Definitive Healthcare is scheduled to release its next quarterly earnings announcement on Thursday, August 4th 2022.
View our earnings forecast for Definitive Healthcare

How were Definitive Healthcare's earnings last quarter?

Definitive Healthcare Corp. (NASDAQ:DH) posted its quarterly earnings data on Thursday, May, 5th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.01 by $0.02. The company had revenue of $50.12 million for the quarter, compared to analysts' expectations of $48.47 million.
View Definitive Healthcare's earnings history

What guidance has Definitive Healthcare issued on next quarter's earnings?

Definitive Healthcare updated its second quarter 2022 earnings guidance on Monday, May, 30th. The company provided EPS guidance of $0.04-$0.05 for the period, compared to the consensus estimate of $0.05. The company issued revenue guidance of $53.00 million-$54.00 million, compared to the consensus revenue estimate of $52.70 million.

Who are Definitive Healthcare's key executives?

Definitive Healthcare's management team includes the following people:
  • Mr. Jason Ronald Krantz, Founder, Chairman & CEO (Age 48, Pay $753.02k)
  • Mr. Robert W. Musslewhite J.D., Pres & Director (Age 52, Pay $260.65k)
  • Mr. Richard Douglas Booth, Chief Financial Officer (Age 53, Pay $477.47k) (LinkedIn Profile)
  • Mr. Scott Oberlink, Chief Technology Officer
  • Mr. David M. Samuels, Chief Legal Officer (Age 59)
  • Mr. Justin A. Steinman, Chief Marketing Officer
  • Mr. Joseph Gianni Mirisola, Chief Revenue Officer (Age 39)
  • Ms. Kate Marie Shamsuddin Jensen, Chief Product Officer (Age 36)
  • Mr. David Kronfeld, Chief Growth Officer
  • Mr. Tom Penque, Chief Talent Officer

When did Definitive Healthcare IPO?

(DH) raised $350 million in an IPO on Wednesday, September 15th 2021. The company issued 15,555,555 shares at a price of $21.00-$24.00 per share.

What is Definitive Healthcare's stock symbol?

Definitive Healthcare trades on the NASDAQ under the ticker symbol "DH."

How do I buy shares of Definitive Healthcare?

Shares of DH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Definitive Healthcare's stock price today?

One share of DH stock can currently be purchased for approximately $23.49.

How much money does Definitive Healthcare make?

Definitive Healthcare (NASDAQ:DH) has a market capitalization of $2.29 billion and generates $166.15 million in revenue each year.

How many employees does Definitive Healthcare have?

Definitive Healthcare employs 676 workers across the globe.

How can I contact Definitive Healthcare?

Definitive Healthcare's mailing address is 550 COCHITUATE ROAD, FRAMINGHAM MA, 01701. The official website for Definitive Healthcare is www.definitivehc.com. The company can be reached via phone at 508-720-4224 or via email at [email protected].

This page (NASDAQ:DH) was last updated on 7/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.